• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8 Back to Search Results
Model Number G8
Device Problems Device Displays Incorrect Message (2591); Device Operational Issue (2914)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/01/2018
Event Type  malfunction  
Manufacturer Narrative
Additional manufacturer narrative: (b)(4).Device evaluation by manufacturer: on (b)(6) 2018, a field service engineer (fse) was dispatched to the customer's facility to address the reported issue.Fse ran controls and observed low areas.Fse found air was entering the sampling system, causing the reported issue.Fse checked rotor seal and stator face, removed fittings on rheydyn valve face plate and flushed ports to make sure they are clear.Fse replaced small syringe due to possible failure to draw sample.Fse replaced sample needle due to air entering system between needle and rheydyn valve.Fse calibrated and ran quality controls (qc) and patient samples.All results and total areas were within acceptable range.The g8 instrument is functioning as intended.No further actions required from field service engineer.A 13-month complaint history review and service history review for serial number (b)(4) from 01-feb-2017 through aware date (b)(6) 2018 for similar complaints was performed.There were no other similar complaints identified during the searched period.The g8 operator's manual under chapter 1, introduction and application, under interpretation of results, provides guidance on the total area and chromatography.Paragraphs three to five state " results will not be reported if the total area (ta) is <500 which can be seen in severe anemia.Results will not be reported if the ta is >4000 which can be seen in polycythemia.(see "abnormal red cell survival in previous section).The optimal goal for total area is between 700-3000.However a ta in the range of 500-4000 is acceptable and reportable for whole blood specimens.The chromatogram must be examined for any unidentifiable peaks (i.E., p00, p01,) before the a0 peak.Do not report the result if these peaks exist.When there is a question concerning the chromatography, repeat the sample.If the repeated sample also displays unusual characteristics, it is appropriate to evaluate whether the unusual result is due to an abnormal sample, a procedural error, an instrument malfunction or a sample-handling problem.For further information, see the troubleshooting section in this operator's manual." in chapter 6 - troubleshooting states, 200 area low error is generated when three successive results below the lower limit of the total area (50) occur.If the error message is present when sufficient volume of sample is set in the rack, the problem may be caused by an empty reagent (hemolysis & wash solution).Operator is instructed to check the remaining volume of hemolysis & wash solution and start the assay again.The most probable cause of the reported event was due to air leaking into sampling system.
 
Event Description
On (b)(6) 2018, customer reported getting 200 low total area (ta; the total area optimal range is 700 to 3000) during quality controls (qc) run on the g8 instrument.Customer noted changing the controls, but was still getting low total area.A field service engineer (fse) was dispatched to address the reported event, which resulted in delay in reporting of patient results for hemoglobin a1c (hba1c).There was no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, japan 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION (MANUFACTURER)
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, japan 10586 23
JA   1058623
Manufacturer Contact
doria esquivel
6000 shoreline court
suite 101
south san francisco, CA 94080
6509368123
MDR Report Key7380223
MDR Text Key103951180
Report Number8031673-2018-00239
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 03/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA03/28/2018
Distributor Facility Aware Date03/01/2018
Device Age8 YR
Event Location Outpatient Treatment Facility
Date Report to Manufacturer03/28/2018
Initial Date Manufacturer Received 03/01/2018
Initial Date FDA Received03/28/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2010
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-